Structure Therapeutics (GPCR) director Waldstreicher received 39,453 Share Option (right to buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Joanne Waldstreicher (director at Structure Therapeutics Inc., GPCR) reported that they received 39,453 Share Option (right to buy) on Jun 17, 2026.
- Reporting person
- Waldstreicher Joanne
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Grant or award (A) | Share Option (right to buy)On 39,453 Ordinary Shares1, 2, 3 | +39,453 | - | - | 39,453 direct |
Holdings before and after
- Share Option (right to buy): 0 to 39,453 direct
Footnotes from the filing
- 1. The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ( ADSs ).
- 2. The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,
- 3. The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Waldstreicher report in this GPCR Form 4?
Joanne Waldstreicher (director at Structure Therapeutics Inc., GPCR) reported that they received 39,453 Share Option (right to buy) on Jun 17, 2026.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for GPCR
Across the 15 sessions after earlier GPCR headlines, the stock closed higher 5 times and lower 10 times, with a median move of 2.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | GPCR | SPY |
|---|---|---|---|
| Jun 8, 2026 | Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity | +0.5% | +0.2% |
| May 27, 2026 | Structure Therapeutics Announces Participation in Upcoming Investor Conferences | -0.1% | -0.0% |
| May 8, 2026 | Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights | -0.1% | +0.8% |
| Apr 28, 2026 | Structure Therapeutics to Present Aleniglipron, Amylin and Combination Data at the American Diabetes Association 86th Scientific Sessions | -3.9% | -0.5% |
| Apr 27, 2026 | Canaccord Genuity initiated coverage on Structure Therapeutics with a new price target | -0.4% | +0.2% |
| Apr 15, 2026 | Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel | +1.9% | +0.8% |
Earlier insider filings at GPCR
- Jun 18, 2026SEC Form 4 filed by Director Dobmeier Eric
- Jun 18, 2026SEC Form 4 filed by Director Tetlow Sharon
- Jun 18, 2026SEC Form 4 filed by Director Welch Daniel G
- Apr 23, 2026COO & GC Lang Matthew was granted 184,614 units of Ordinary Shares (SEC Form 4)
- Apr 16, 2026SEC Form 4 filed by Fmr Llc
Keep researching GPCR
- GPCR insider tradesEvery buy and sale reported by Structure Therapeutics Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- GPCR earnings historyPast Structure Therapeutics Inc. earnings releases, newest first.
- GPCR financial statementsRevenue, profit, cash flow and balance sheet from Structure Therapeutics Inc.'s SEC filings.
Quantisnow market dataNASDAQ
GPCR
Structure Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2023
Get push alerts for GPCR
Full GPCR profile on Quantisnow Follow GPCR and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time